SPECTRUM PHARMACEUTICALS INC Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2010 to Q1 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Spectrum Pharmaceuticals Inc quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2010 to Q1 2023.
  • Spectrum Pharmaceuticals Inc Weighted Average Number of Shares Outstanding, Basic for the quarter ending March 31, 2023 was 202M shares, a 19% increase year-over-year.
  • Spectrum Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 183M shares, a 18.3% increase from 2021.
  • Spectrum Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 155M shares, a 24.5% increase from 2020.
  • Spectrum Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2020 was 124M shares, a 12.5% increase from 2019.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 202M +32.2M +19% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 183M +28.4M +18.3% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-31
Q3 2022 188M +29.1M +18.3% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 176M +20.3M +13.1% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-12
Q1 2022 170M +24.4M +16.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 155M +30.5M +24.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 159M +27.8M +21.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 155M +42.6M +37.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 145M +33.6M +30.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 124M +13.8M +12.5% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-18
Q3 2020 131M +20.3M +18.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 113M +2.27M +2.06% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 112M +2.23M +2.03% Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-07
Q4 2019 111M Oct 1, 2019 Dec 31, 2019 10-K 2020-03-02
Q3 2019 111M +7.07M +6.79% Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-07
Q2 2019 110M +7.75M +7.55% Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-09
Q1 2019 110M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q3 2018 104M +20.6M +24.7% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 103M +24M +30.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q3 2017 83.5M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 78.6M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2014 63.4M +4.27M +7.21% Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-12
Q4 2013 60.7M +2.14M +3.65% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-14
Q3 2013 61.9M +2.99M +5.08% Jul 1, 2013 Sep 30, 2013 10-Q 2013-11-18
Q2 2013 59M +214K +0.36% Apr 1, 2013 Jun 30, 2013 10-Q 2013-08-09
Q1 2013 59.2M +717K +1.23% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 58.6M +5.32M +9.98% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-13
Q3 2012 58.9M +5.1M +9.48% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-18
Q2 2012 58.8M +6.51M +12.5% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 58.5M +7.17M +14% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 53.3M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-12
Q3 2011 53.8M +4.07M +8.19% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 52.3M +3.24M +6.6% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-08
Q1 2011 51.3M Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-27
Q3 2010 49.7M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-28
Q2 2010 49M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.